Lecicarbon E Co2-Laxans Drei (Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate)

The sodium hydrogen carbonate and sodium dihydrogen phosphate create an osmotic gradient when introduced into the rectum. This gradient pulls water from surrounding tissues into the colon, increasing luminal fluid, softening feces, and stimulating peristalsis to promote evacuation.

The appropriate dose and frequency are determined by the prescribing healthcare professional based on the patient’s condition, age, and response. Patients should follow the prescriber’s instructions and the product label.

Safety data for use in pregnancy or lactation are limited. Healthcare providers should evaluate the risk‑benefit profile for each individual. If use is considered necessary, it should be under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with stimulant laxatives, Lecicarbon E works osmotically, drawing water into the colon rather than stimulating intestinal muscle directly. This often results in a gentler onset of action and a lower risk of cramping, though it may be slower than stimulant agents for acute relief.

Store the enema solution at room temperature, below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme temperatures to maintain stability and efficacy.

The product is administered rectally. The prescribed volume is inserted into the rectum using the supplied applicator or a suitable enema device, allowing the solution to contact the colonic mucosa. The patient should retain the enema for the time recommended by the prescriber.

Serious risks include severe abdominal pain, electrolyte imbalance (especially hypernatremia), dehydration with excessive use, and rare allergic reactions. Patients should seek immediate medical attention if they experience intense pain, swelling, rash, or signs of electrolyte disturbance.

The enema should be avoided in individuals with known hypersensitivity to the ingredients, intestinal obstruction, severe dehydration, or active rectal bleeding. It is also contraindicated in patients for whom osmotic laxatives are medically inadvisable, as determined by a healthcare professional.